These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

346 related articles for article (PubMed ID: 25138313)

  • 41. Clinical effectiveness of cardiac resynchronization and implantable cardioverter-defibrillator therapy in men and women with heart failure: findings from IMPROVE HF.
    Wilcox JE; Fonarow GC; Zhang Y; Albert NM; Curtis AB; Gheorghiade M; Heywood JT; Mehra MR; O'Connor CM; Reynolds D; Walsh MN; Yancy CW
    Circ Heart Fail; 2014 Jan; 7(1):146-53. PubMed ID: 24178311
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Association between myocardial substrate, implantable cardioverter defibrillator shocks and mortality in MADIT-CRT.
    Sood N; Ruwald AC; Solomon S; Daubert JP; McNitt S; Polonsky B; Jons C; Clyne CA; Zareba W; Moss AJ
    Eur Heart J; 2014 Jan; 35(2):106-15. PubMed ID: 24179073
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Anxiety and risk of ventricular arrhythmias or mortality in patients with an implantable cardioverter defibrillator.
    Habibović M; Pedersen SS; van den Broek KC; Theuns DA; Jordaens L; van der Voort PH; Alings M; Denollet J
    Psychosom Med; 2013 Jan; 75(1):36-41. PubMed ID: 23197843
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Benefit of combined resynchronization and defibrillator therapy in heart failure patients with and without ventricular arrhythmias.
    Ypenburg C; van Erven L; Bleeker GB; Bax JJ; Bootsma M; Wijffels MC; van der Wall EE; Schalij MJ
    J Am Coll Cardiol; 2006 Aug; 48(3):464-70. PubMed ID: 16875970
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Antiarrhythmic effect of reverse ventricular remodeling induced by cardiac resynchronization therapy: the InSync ICD (Implantable Cardioverter-Defibrillator) Italian Registry.
    Di Biase L; Gasparini M; Lunati M; Santini M; Landolina M; Boriani G; Curnis A; Bocchiardo M; Vincenti A; Denaro A; Valsecchi S; Natale A; Padeletti L;
    J Am Coll Cardiol; 2008 Oct; 52(18):1442-9. PubMed ID: 19017510
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Incidence and predictors of implantable cardioverter-defibrillator therapy in patients with arrhythmogenic right ventricular dysplasia/cardiomyopathy undergoing implantable cardioverter-defibrillator implantation for primary prevention.
    Bhonsale A; James CA; Tichnell C; Murray B; Gagarin D; Philips B; Dalal D; Tedford R; Russell SD; Abraham T; Tandri H; Judge DP; Calkins H
    J Am Coll Cardiol; 2011 Sep; 58(14):1485-96. PubMed ID: 21939834
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The clinical course of patients with implantable cardioverter-defibrillators: Extended experience on clinical outcome, device replacements, and device-related complications.
    van der Heijden AC; Borleffs CJ; Buiten MS; Thijssen J; van Rees JB; Cannegieter SC; Schalij MJ; van Erven L
    Heart Rhythm; 2015 Jun; 12(6):1169-76. PubMed ID: 25749138
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Effect of cardiac resynchronization therapy on beat-to-beat T-wave amplitude variability.
    Žižek D; Cvijić M; Tasič J; Jan M; Frljak S; Zupan I
    Europace; 2012 Nov; 14(11):1646-52. PubMed ID: 22423254
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Long-term impact of cardiac resynchronization therapy in mild heart failure: 5-year results from the REsynchronization reVErses Remodeling in Systolic left vEntricular dysfunction (REVERSE) study.
    Linde C; Gold MR; Abraham WT; St John Sutton M; Ghio S; Cerkvenik J; Daubert C;
    Eur Heart J; 2013 Sep; 34(33):2592-9. PubMed ID: 23641006
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Effect of obesity on the effectiveness of cardiac resynchronization to reduce the risk of first and recurrent ventricular tachyarrhythmia events.
    Szepietowska B; Polonsky B; Sherazi S; Biton Y; Kutyifa V; McNitt S; Aktas M; Moss AJ; Zareba W
    Cardiovasc Diabetol; 2016 Jul; 15():93. PubMed ID: 27388610
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Reduction of the risk of recurring heart failure events with cardiac resynchronization therapy: MADIT-CRT (Multicenter Automatic Defibrillator Implantation Trial With Cardiac Resynchronization Therapy).
    Goldenberg I; Hall WJ; Beck CA; Moss AJ; Barsheshet A; McNitt S; Polonsky S; Brown MW; Zareba W
    J Am Coll Cardiol; 2011 Aug; 58(7):729-37. PubMed ID: 21816309
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The impact of nonsustained ventricular tachycardia on reverse remodeling, heart failure, and treated ventricular tachyarrhythmias in MADIT-CRT.
    Mittal S; Aktas MK; Moss AJ; McNitt S; Kutyifa V; Steinberg JS; Zareba W
    J Cardiovasc Electrophysiol; 2014 Oct; 25(10):1082-7. PubMed ID: 24862906
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Cardiac Resynchronization Therapy in CKD Stage 4 Patients.
    Höke U; Khidir MJ; van der Velde ET; Schalij MJ; Bax JJ; Delgado V; Marsan NA
    Clin J Am Soc Nephrol; 2015 Oct; 10(10):1740-8. PubMed ID: 26408549
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Relationship between improvement in left ventricular dyssynchrony and contractile function and clinical outcome with cardiac resynchronization therapy: the MADIT-CRT trial.
    Pouleur AC; Knappe D; Shah AM; Uno H; Bourgoun M; Foster E; McNitt S; Hall WJ; Zareba W; Goldenberg I; Moss AJ; Pfeffer MA; Solomon SD;
    Eur Heart J; 2011 Jul; 32(14):1720-9. PubMed ID: 21609974
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Influence of diabetes mellitus on inappropriate and appropriate implantable cardioverter-defibrillator therapy and mortality in the Multicenter Automatic Defibrillator Implantation Trial-Reduce Inappropriate Therapy (MADIT-RIT) Trial.
    Ruwald MH; Zareba W; Jons C; Zhang C; Ruwald AC; Olshansky B; McNitt S; Bloch Thomsen PE; Shoda M; Merkely B; Moss AJ; Kutyifa V
    Circulation; 2013 Aug; 128(7):694-701. PubMed ID: 23881862
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Reduced appropriate implantable cardioverter-defibrillator therapy after cardiac resynchronization therapy-induced left ventricular function recovery: a meta-analysis and systematic review.
    Chatterjee NA; Roka A; Lubitz SA; Gold MR; Daubert C; Linde C; Steffel J; Singh JP; Mela T
    Eur Heart J; 2015 Nov; 36(41):2780-9. PubMed ID: 26264552
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Effect of metoprolol versus carvedilol on outcomes in MADIT-CRT (multicenter automatic defibrillator implantation trial with cardiac resynchronization therapy).
    Ruwald MH; Ruwald AC; Jons C; Alexis J; McNitt S; Zareba W; Moss AJ
    J Am Coll Cardiol; 2013 Apr; 61(14):1518-26. PubMed ID: 23500269
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Incidence of ventricular arrhythmias in patients with severe left ventricular systolic dysfunction: is there a benefit after cardiac resynchronization therapy?].
    Timóteo AT; Oliveira MM; Silva MN; Toste A; Ramos R; Feliciano J; Cunha PS; Soares R; Santos S; Ferreira RC
    Rev Port Cardiol; 2011 Nov; 30(11):823-8. PubMed ID: 22032954
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Impact of cardiac resynchronization therapy on clinical outcomes in patients with continuous-flow left ventricular assist devices.
    Gopinathannair R; Birks EJ; Trivedi JR; McCants KC; Sutton BS; Deam AG; Slaughter MS; Hottigoudar RU
    J Card Fail; 2015 Mar; 21(3):226-32. PubMed ID: 25528199
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Reduced risk of life-threatening ventricular tachyarrhythmias with cardiac resynchronization therapy: relationship to left ventricular ejection fraction.
    Kutyifa V; Moss AJ; Solomon SD; McNitt S; Aktas MK; Barsheshet A; Merkely B; Zareba W; Goldenberg I
    Eur J Heart Fail; 2015 Sep; 17(9):971-8. PubMed ID: 26173635
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.